Inspire Medical Systems Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名54/206位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价130.32。中期看,股价处于上升通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Inspire Medical Systems Inc评分
相关信息
行业排名
54 / 206
全市场排名
140 / 4562
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
20
位分析师
买入
评级
130.322
目标均价
-9.49%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Inspire Medical Systems Inc亮点
亮点风险
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
公司代码INSP
公司Inspire Medical Systems Inc
CEOHerbert (Timothy P)
网址https://www.inspiresleep.com/
常见问题
Inspire Medical Systems Inc(INSP)的当前股价是多少?
Inspire Medical Systems Inc(INSP)的当前股价是 95.390。
Inspire Medical Systems Inc的股票代码是什么?
Inspire Medical Systems Inc的股票代码是INSP。
Inspire Medical Systems Inc股票的52周最高点是多少?
Inspire Medical Systems Inc股票的52周最高点是216.010。
Inspire Medical Systems Inc股票的52周最低点是多少?
Inspire Medical Systems Inc股票的52周最低点是70.770。
Inspire Medical Systems Inc的市值是多少?
Inspire Medical Systems Inc的市值是2.77B。
Inspire Medical Systems Inc的净利润是多少?
Inspire Medical Systems Inc的净利润为53.51M。
现在Inspire Medical Systems Inc(INSP)的股票是买入、持有还是卖出?
根据分析师评级,Inspire Medical Systems Inc(INSP)的总体评级为买入,目标价格为130.322。
Inspire Medical Systems Inc(INSP)股票的每股收益(EPS TTM)是多少
Inspire Medical Systems Inc(INSP)股票的每股收益(EPS TTM)是1.499。